$17.22
$0.28
(1.65%)
Quote as of 1:17 PM EST on 02/15/12
Emergent BioSolutions
NYSE:EBS
|
$17.22
|
|
| Today's Open | $16.99 |
|---|---|
| Previous Close | $16.94 |
| Daily Range | $16.89 - $17.33 |
| 52-Week Range | $14.90 - $26.41 |
| Market Cap | $619.11M |
| P/E Ratio | 26.89 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 39,163 |
| Average Daily Volume | 139,202 |
| Current FY EPS | $0.57 |
EBS Information
| Description |
|---|
| Emergent BioSolutions makes the only FDA-approved anthrax vaccine. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
US Stock Futures: HOT STOCKS TO WATCH
Abbott To End Development Deal With Emergent On Cancer Drug
US Stock Futures: HOT STOCKS TO WATCH
Biotech Post-Holiday Regifting
The Highest-Rated Biotech Stocks
The 8 Highest Potential Returns in Biotechnology
Whoa! My Stock Just Whomped the Market!
Emergent BioSolutions Shares Jumped: What You Need to Know
5-Star Stocks Poised to Pop: Emergent BioSolutions
Emergent BioSolutions' CEO Discusses Q2 2011 Results - Earnings Call Transcript
